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Abstract.  In this  study we have found that the phos- 
phoprotein  doublet of 68,000 and 65,000 daltons 
(68/65  kD)  in mouse T-lymphoma cells shares  several 
structural  and functional  similarities  with erythrocyte 
band 4.1.  Our evidence for identifying the 68/65-kD 
doublet as a lymphoma 4.l-like protein  is as follows: 
(a)  it displays an immunological  cross-reactivity  with 
anti-erythrocyte  band 4.1  antibody;  (b) it exhibits a 
Svedberg unit of sedimentation  coefficient of 4  S;  (c) 
it is phosphorylated  in the presence of phorbol ester 
(phorbol-12-O-tetradecanoylphorbol-B-acetate)  and its 
phosphorylation  requires  Ca2+; (d)  it is phosphory- 
later primarily  at serine residues;  and (e) it can bind 
directly to fodrin (a spectrin-like  actin-binding  pro- 
tein).  In addition,  this  lymphoma 4.l-like protein can 
be both colocalized and coisolated with the major 
T-lymphocyte-specific glycoprotein,  Thy-1  (gp 25). 
Therefore,  all of these results  strongly  suggest that the 
lymphoma 4.l-like protein  (68/65-kD  doublet) may 
play a pivotal role in linking  the Thy-1  (gp 25) glyco- 
protein to fodrin which,  in turn,  binds to the actin 
filaments  that are responsible for recruiting  Thy-1  anti- 
gens into cap structures. 
T 
He Thy-1 antigen was first identified as a cell surface 
alloantigen (having two allotypic forms called Thy-l,1 
and  Thy-l,2)  on thymus  and  brain  cells  from mice 
(55). The Thy-1 glycoprotein (25,000 D) is one of the most 
abundant  membrane  components  in  both  thymocytes and 
neurons of rodents (7, 55). Immunoreactive forms of Thy-1 
have also been detected in dog and human brain tissue (3, 
27). Amino acid sequence data indicate that the Thy-1 protein 
shares a large amount of sequence and structural homology 
with a single immunoglobulin-variable  domain (24). 
Although the Thy-1 glycoproteins display properties of in- 
tegral  membrane proteins,  no intramembraneous  or trans- 
membrane hydrophobic amino acid sequence has been de- 
tected (20).  Recently, it has been suggested that the Thy-1 
antigens are anchored in the plasma membrane via a phos- 
pholipid, possibly one with a phosphoinositol domain (44, 
65). However, this hypothesis has been challenged by cDNA 
sequence analysis which suggests that a segment of 31 amino 
acids at the carboxyl terminus of the Thy-1 molecules may 
be responsible  for the  integration  of this protein  into  the 
plasma membrane (21, 57). Until these conflicting pieces of 
evidence can be clarified, the question of whether the Thy-1 
antigens penetrate  into the plasma membrane remains un- 
resolved. 
Antibodies to Thy-1  are known to induce Thy-1  antigens 
to form surface receptor clusters and aggregates: the so-called 
patching and capping phenomenon (11, 12). This antibody- 
induced Thy-1  antigen redistribution  appears to be closely 
correlated with certain physiologically relevant events. For 
example, proliferation of mouse T-lymphocytes is known to 
result from the clustering of Thy-1 antigens by anti-Thy-1  an- 
tibody (35, 45, 46); and the outgrowth of neuronal processes 
in tissue culture is facilitated by anti-Thy-1  antibody binding 
to their receptors (41). In addition,  anti-Thy-1  patching and 
capping display the following characteristics: (a) the patched 
and capped structures are closely associated with a number 
of cytoskeletal proteins (e.g., actin and myosin) (13, 17); (b) 
the capping process is sensitive to microfilament-disrupting 
agents (cytochalasins B and D), implying that the function 
of microfilaments is important for Thy-1 antigen movement 
(B); and (c) actin polymerization occurs concomitantly with 
Thy-1 cap formation (40). These results provide strong evi- 
dence for the direct involvement of the cytoskeleton in the 
mechanism of Thy-1 antigen movement. 
Recently,  immunoreactive  forms of band 4.1  have been 
identified in brain tissue (6, 33), in fibroblasts (23), and in 
several blood cell types such as lymphocytes, platelets, and 
polymorphonuclear leukocytes (62).  In these nonerythroid 
cells, the immunoreactive 4.1 proteins appear as either a sin- 
glet or a doublet with apparent molecular masses ranging 
from 68,000 to 75,000 D after SDS PAGE (8). Synapsin, one 
of the  major  components  of synaptic  vesicles,  has  been 
shown to display a number of biochemical properties similar 
to those described for both erythrocyte 4.1 and brain 4.l-like 
protein (6). In erythrocytes, band 4.1 has been shown to en- 
hance  the  interaction  between spectrin  and actin  (22,  52, 
68). In addition, band 4.1 protein also binds to the erythro- 
cyte transmembrane glycoproteins, glycophorin and band 3 
protein (the anion transport channel protein) (1, 53). Unfor- 
tunately, the structural or functional involvement of 4. l-like 
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types such as lymphocytes, platelets, and polymorphonucle- 
ar leukocytes is unclear at the present time. 
In this study we have found that a 68,000/65,000-D phos- 
phoprotein  doublet (designated 68/65-kD)  in T-lymphoma 
cells also displays  immunoreactivity  with  the  erythrocyte 
membrane skeletal protein, band 4.1. The 68/65-kD doublet 
shares several structural and functional similarities with the 
erythrocyte 4.1 protein. Additionally, the lymphoma 4.l-like 
protein can be colocalized and co-isolated with the major 
T-lymphocyte-specific glycoprotein,  Thy-1 by complemen- 
tary techniques including double immunofluorescence stain- 
ing,  immunoprecipitation,  and sucrose gradient centrifuga- 
tion.  Furthermore,  our  data  indicates  that  the  lymphoma 
4.l-like  protein  (but not Thy-1) binds to fodrin  which,  in 
turn,  then is able to bind to actin filaments.  It is proposed 
that the lymphoma 4.l-like  protein plays a pivotal role in 
linking Thy-1 to the cytoskeleton which is required for col- 
lecting Thy-1  antigens  into cap structures. 
Materials and Methods 
Cells 
The mouse T-lymphoma cell line, BW 5147, an AKR/J lymphoma line (ob- 
tained from Dr. R. Hyman, The Salk Institute, San Diego, CA) were grown 
in  DME  supplemented with  10%  heat-inactivated horse serum  (Gibco, 
Grand Island, NY) at 37°C in 5% CO2/95%  air. 
Immunofluorescence Microscopy 
Surface Labeling. Cells were stained for surface Thy-1 (gp 25) patching and 
capping by first washing with RPMI 1640 medium and then treating these 
cells with primary antibodies (monoclonal rat antibodies) raised against 
Thy-1 (gifts kindly provided by Dr. fan Trowbridge, The Salk Institute) fol- 
lowed by the addition of a secondary antibody such as fluorescein-conju- 
gated goat anti-rat IgG at room temperature or 37°C for 20 min. 
Intracellular Labeling of  4.1 Protein. Fluorescein-labeled Thy-I (gp 25) 
patched/capped cells were fixed with 2% paraformaldehyde in 0.1 M phos- 
phate buffer (pH 7.4) at 0°C for 30 min, rendered permeable by methanol 
treatment (19),  and then stained with rabbit anti-erythrocyte 4.1  protein 
(generously supplied by Dr.  Van Bennett, The Johns Hopkins University, 
Baltimore,  MD).  These samples were then incubated with rhodamine- 
conjugated goat antibody against rabbit IgG to visualize the distribution of 
protein 4.1. To detect any nonspecific antibody binding, permeabilized cells 
were first incubated with antisera that were preabsorbed with soluble, native 
erythrocyte 4.1 protein to remove anti-protein 4.1  antibodies. These sam- 
ples were then incubated with rhodamine-conjugated goat anti-rabbit IgG. 
No label was observed in such control samples. 
These fluorescein and rhodamine-labeled samples were examined under 
a  Zeiss  photomicroscope  using  a  63×  oil-immersion  lens  with  epi- 
illumination and filter system of CZ 487710 and CZ 487714,  respectively. 
Cells were photographed on Kodak plus-X film (Eastman Kodak Co., Roch- 
ester, NY). 
Phorbol Ester Treatment 
Phorbol ester, such as phorboM2-O-tetradecanoylphorbol-13-acetate  (TPA), 
was purchased from Sigma Chemical Co. (St. Louis, MO). This reagent 
was then dissolved in DMSO (final concentration of 1%) and used at a final 
concentration of l0  -7 M. In control samples, cells were incubated in either 
DMSO plus phosphate-free DME or in phosphate-free DME alone. After 
incubation, aliquots were removed and cells were processed for further 
analysis as described below. 
Radioactive Labeling of  Cellular Proteins 
Labeling Proteins with USl. Surface proteins and cellular proteins were la- 
beled with m2sI using the iodogen method of Fraker and Speck (30). 
Labeling  Proteins  with  [35S]Methionine or [aH]Glucosamine.  Cell 
cultures  (1  x  l0  s cells/ml) were  incubated either with  [3SS]methionine 
(1,000 Ci/mmol) (for labeling total cellular proteins) or with [3H]glucosa- 
mine (100 Ci/mmol) (for labeling glycoproteins) (ICN K & K laboratories, 
Inc., Plainview,  NY) for 16 h at 37"C in DME supplemented with 10% heat- 
inactivated horse serum in 5 % CO2/95 % air. 
Protein Phosphorylation.  (a) Labeling in vivo: To metabolically label 
cellular phosphoproteins, cells (1  x  107 cellsdml) were washed with phos- 
phate-free DME, and H332po4 (carrier free, ICN K & K laboratories Inc.) 
was then added at 0.25  mCi/ml. After 1 h of incubation with H332po4 at 
37°C (isotopic equilibrium inside the cell is reached under this condition), 
cells were exposed to TPA or phosphate-free  DME alone for 10 min at room 
temperature. (b) Labeling in vitro: Isolated plasma membrane (prepared ac- 
cording to the procedures described below) was incubated in 20 mM KCI, 
1 mM Mg acetate, 10-4-10  -6 M Ca  2+ (pCa =  -log~104-6  =  4.0-6.0) and 
1 mM ['/-32p]ATP (100-200  cpm/pmol) (ICN Chemical and Radioisotope 
Division, Irvine, CA) for 5 min at 30°C. As a control,  10-4-10  -6 M Ca  2+ 
(pCA  =  4.0-6.0,  high  Ca 2+)  was  replaced by  10  -s  M  Ca  2+  (pCa  2+  = 
-log~010 s =  8.0, low or no Ca  2+) in the incubation mixture. Phosphoryla- 
tion was terminated by adding an excess amount of unlabeled 0.1  M PBS 
(pH 7.4) at 0°C. 
Plasma Membrane Isolation 
Plasma membrane was isolated by the method described by Johnson and 
Bourne (37) with slight modifications. Radioactively labeled samples (i.e., 
J2SI-labeled, [3H]glucosamine-labeled, [35S]methionine-labeled,  or 32po4- 
labeled cells) were harvested by low speed centrifugation  (500 g~), washed 
twice with Dulbecco's phosphate-buffered medium and resuspended in a 
solution  of  20  mM  Hepes,  2  mM  MgCI2,  1  mM  EDTA,  1  mM 
phenylmethylsulfonyl fluoride (PMSF), 1 lag/ml aprotinin, 1 pg/ml leupep- 
tin, 1 mM 2-mercaptoethanol, pH 7.4, at 0°C. These cells were then lysed 
by homogenization with a Dounce homogenizer. The lysate was centrifuged 
at 750 g~ for 5 min and the resulting supernatant centrifuged at 43,000 gay 
for 20 min. The pellet was resuspended in 10% sucrose (wt/wt) in the same 
buffer,  layered  over  a  discontinuous gradient  of 30  and  40%  sucrose 
(wt/wt), and spun at 150,000 g~, for 90 min. The plasma membrane frac- 
tion was collected from the 30-40% interface and washed with phosphate- 
buffered Earle's balanced salt solution, pH 7.3. Enzyme marker assays (5' 
nucleotidase and/or Na÷/K+-ATPase  activities) showed that these plasma 
membrane preparations were at least 20-fold purified and contained negligi- 
ble amounts of other membranous organelle contamination (13). 
NP-40 Extraction 
Isolated plasma membrane was  washed and  resuspended in  phosphate- 
buffered Earle's balanced salt solution containing 1 mM PMSF and 10 mM 
iodoacetamide. Detergent extraction was accomplished by adding NP-40 to 
the phosphate-buffered  Earle's balanced salt solution to a final concentration 
of 1%  (vol/vol).  Protein concentration in all  samples was kept at  ,00.5 
mg/ml. The samples were incubated at 0°C for 20 min with frequent vortex- 
ing and then centrifuged at  100,000 g,v for 45 min. After centrifugation, 
the supernatant (i.e., the NP-40-soluble fraction) and the pellet (i.e., NP- 
40-insoluble fraction) were collected for further biochemical analysis as de- 
scribed previously (14, 16). Previous studies have shown that the NP-40-in- 
soluble fraction contains the membrane-associated cytoskeleton (13, 16). 
Immunoblotting and Immunoprecipitation Procedures 
Isolated erythrocyte ghost membranes and mouse lymphoma membranes 
were electrophoresed either on an exponential polyacrylamide gel gradient 
(6.0-17.0) or a 12% polyacrylamide gel that contained SDS as described be- 
low. The polypeptides were transferred to nitrocellulose sheets as described 
previously (16). Nitrocellulose sheets were subsequently incubated with 
anti-erythrocyte 4.1 antibody, followed by incubation with 125I-protein A, 
and analyzed by autoradiography as described below. 
32p_, J251_  '  or [3H]Glucosamine-labeled detergent-extracted total mouse 
lymphoma plasma membranes, cytoskeletal fractions, or isolated proteins 
were incubated with either rabbit anti-erythrocyte 4.1 protein or anti-eryth- 
rocyte 4.1 protein-free (preabsorbed) antiserum at 4°C for 30 min. Anti-4.1 
antibody was preabsorbed by an excess amount (at least 1130 ttg/ml) of the 
erythrocyte band 4.1.  Subsequently, goat anti-rabbit IgG was added to the 
samples at 4°C for 30 min to precipitate the immune complex. The im- 
munoprecipitates were obtained by centrifugation at 700 g~ for 5 min and 
washed three times with 0.1% NP-40 in phosphate-buffered  Earle's balanced 
salt solution using the same centrifugation conditions. To detect Thy-1 anti- 
gens, similar immunoprecipitation procedures were carried out using NP- 
40-solubilized,  ~2SI-labeled plasma  membranes.  Either  monoclonal  rat 
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anti-rat and goat anti-rabbit IgG was added to the samples at 4°C for 1 h 
to generate the immunocomplexes.  The immunoprecipitates  were  subse- 
quently solubilized by SDS, and analyzed by SDS PAGE and autoradiogra- 
phy as described below. 
Immunobinding Procedures 
Antigenically  active molecules were detected by binding with rat anti-Tby-1 
(gp 25)-conjugated Sepharose  beads.  Antibody was  coupled  to  CNBr- 
activated Sepharose 4B beads (Pharmacia Fine Chemicals, Piscataway, NJ) 
according to the method outlined by Cuatrecasas (26).  125I-labeled mem- 
brane proteins were incubated with these antibody-conjugated  beads for 
2 h. The beads were then poured into small columns and washed extensively 
with 0.1% NP-40. As a control for nonspecific binding, beads were prepared 
with preabsorbed anti-Thy-1  antiserum (anti-Thy-I  antibodies were  re- 
moved with excess Thy-1 antigens).  Proteins bound to the anti-Thy-l-con- 
jugated beads  were  detected  by counting on a  Beckman 5500 Gamma 
counter (Beckman Instruments Inc., Palo Alto,  CA). 
SDS PAGE and Autoradiographic Analysis 
Electrophoresis was conducted using an exponential  polyacrylamide  gra- 
dient (6.0-17.0%) slab gel and the discontinuous  buffer system described by 
Laemmli (39).  All samples were dissolved  in a buffer that contained 2% 
SDS, 0.1  M 2-mercaptoethanol, 0.003%  bromophenol blue, 20 mM Tris- 
HC1, pH 6.8, and then heated to 100°C for 2 rain. Electrophoresis was con- 
ducted at a constant current of 15 mA at room temperature for 4 h. The poly- 
peptide banding pattern was revealed by staining with Coomassie Blue. Gels 
containing samples labeled with ~2sI-, 3~p., [3H]glucosamine ' or [35S]methi- 
onine were processed through fluorography  (10), vacuum dried,  and ex- 
posed to Kodak x-ray (X-Omat  XAR-5)  film at  -70°C. 
Phosphoamino Acid Analysis 
The 32p-labeled 68/65-kD protein isolated  from cells that were labeled ei- 
ther in the presence or absence of TPA was recovered from polyacrylamide 
gel slices by electroelution  as described by Hunkapiller et al. (36) with the 
exception  that a Hoeffer cylindrical  gel apparatus was used as the elution 
tank.  Hydrolysis  of the eluted  protein was performed at ll0°C for 2 h by 
the method of Cooper et al.  (25) and the phosphoamino acids were sepa- 
rated  by conventional  two-dimensional  paper chromatography  on 3-mm 
Whatman chromatographic  paper (Whatman Inc., Clifton, N  J). Separation 
in the first dimension was achieved at pH 3.5 for 2 h at 2,000 V, and in the 
second dimension at pH 1.9 for 30 min. The phosphoamino acid standards 
(i.e., phosphoserine, phosphothreonine, and phosphotyrosine) were mixed 
with 32P-labeled samples, co-analyzed  and identified by ninhydrin staining. 
The labeled phosphoamino acids were detected by exposing to Kodak x-ray 
(X-Omat  XAR-5)  film at  -70°C. 
Analysis of  NP-40-solubilized Plasma Membrane by 
Sucrose Gradient Centrifugation 
Isolated  t25I-, [35S]methionine-, or [3H]glucosamine-labeled  plasma mem- 
brane was extracted  with 1% NP-40 and then loaded onto a 36-ml linear 
sucrose gradient (7-48 % in phosphate-buffered  Earle's balanced salt solu- 
tion, pH 7.2) with a 2-ml cushion of saturated  sucrose.  The gradient was 
centrifuged  at 70,000 gay for  12 h.  Parallel  gradients  containing protein 
standards of tetrameric fodrin or spectrin (11 S) (32) and apoferritin (18 S) 
(61) were used to determine the S value of the gp 25-enriched peak. Thirty- 
six  1-ml fractions were  collected  from the bottom of each tube.  The in- 
dividual fractions from the gradient were analyzed by either liquid scintilla- 
tion counting (for [35S]methionine and [3H]glucosamine labels) or gamma 
counting (for nSI-surface  labeled or nSl-labeled total cellular proteins). In- 
dividual  or peak  fractions  (depending  upon the radioactive  label) were 
precipitated  with 10% TCA, and subsequently  analyzed by SDS PAGE and 
autoradiography. The relative amounts of gp 25 (Thy-1) to other surface pro- 
teins in each gradient fraction were determined by scanning densitometry 
(Quick Scan R &  D; Helena Laboratories,  Beaumont, TX) of autoradio- 
grams from t25I-surface labeled or [3H]glucosamine-labeled  materials.  To 
quantitate the relative molar ratio of the 68/65-kD protein and gp 25 in the 
28-S complex,  autoradiograms  of [35S]methionine-labeled or  mI-labeled 
material  were also analyzed  by scanning densitometry. 
Figure 1.  Identification of Thy- 
1 antigen in mouse T-lympho- 
ma  plasma  membranes.  (A) 
Autoradiogram of [3H]glucos- 
amine-labeled  total  plasma 
membranes. (B and C) Auto- 
radiogram of [3H]glucosamine- 
labeled  plasma  membranes 
that  are  immunoprecipitated 
by either monoclonal rat anti- 
Thy-1 (B) or preabsorbed anti- 
Thy-1  (anti-Thy-l-free)  anti- 
sera  (C)  followed  by  rabbit 
anti-rat  antibodies  and  goat 
anti-rabbit  antibodies.  (Mo- 
lecular  mass  markers  [×103  ] 
are  as  follows:  myosin, 
200,000;  [3-galactosidase, 
130,000 ;  lactoperoxidase, 
78,000;  BSA,  68,000;  actin, 
42,000;  concanavalin  A, 
25,000.  These markers repre- 
sent molecular weight values 
indicated in all subsequent gel 
figures.) (D) Immunofiuores- 
cence  staining  of Thy-I  cap- 
ping  induced  by  monoclonal 
rat  anti-Thy-1  and  fluores- 
cein-conjugated goat  anti-rat 
antibodies. Bar,  13  jim. 
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ma  membranes.  (A)  Coomassie Blue- 
stained total plasma membrane. (B) Au- 
toradiogram of ~25I-labeled  total plasma 
membrane. (C) Coomassie Blue-stained 
NP-40-soluble  fraction  of the  plasma 
membrane. (D) Autoradiogram of °ZI-la- 
beled proteins associated with the NP- 
40-soluble fraction of the plasma mem- 
brane. (E) Coomassie Blue-stained NP- 
40-insoluble fraction (i.e., cytoskeleton 
material) of the plasma membrane.  (F) 
Autoradiogram  of  ~25I-labeled  proteins 
associated  with  the  NP-40-insoluble 
fraction (i.e.,  cytoskeleton material)  of 
the plasma membrane. 
Dissociation of  Lymphoma 68/65-kD Protein  from 28 S 
(Thy-1/4.1 Complex) By Urea 
Fractions containing ~25I-Thy-1/4.1 or total  v-SI-labeled Thy-1/4.1  complex 
material (gradient fractions 16-20) were pooled, the sucrose was diluted by 
the addition of phosphate-buffered Earle's balanced salt solution, and cen- 
trifuged at 150,000 gay for 3 h. The pelleted material was then resuspended 
in  a  small  volume of phosphate-buffered Earle's  balanced  salt  solution 
(100-200  Ixl) containing 2 M urea. The samples were incubated at 20°C for 
1 h and then centrifuged in a Beckman airfnge for 40 min at 24 psi (100,000 
g~). The supernatants and pellets were then counted on a Beckman 5500 
Gamma counter to determine the amount of radioactivity that was extracted 
into the superuataut during extraction. The extract was then run over a con- 
canavalin A-Sepharose column to remove any Thy-I molecules that were re- 
moved along with the 4.l-like proteins during extraction. The extracted ma- 
terial (free of contaminating Thy-1  molecules) was then dialyzed against 
20 mM KCI, 10 mM Tris-HCl, pH 8.0, containing 0.5% NP-40.  This mate- 
rial was then loaded onto a 16-ml linear sucrose gradient (7-28% in 10 mM 
Tris-HC1,  pH 8.0, 20 mM KCI) with a 0.5-ml cushion of 65% sucrose. The 
gradient was centrifuged at 70,000 g~ for 22 h. Thirty-two 0.5-ml fractions 
were collected from the bottom of each tube.  The  fractions were then 
counted on a Beckman 5500 Gamma counter to determine the distribution 
of iodinated protein and analyzed by SDS PAGE and autoradiography. The 
iodinated peak material from this gradient was then immunoprecipitated 
with rabbit anti-erythrocyte band 4.1  (as described above) to confirm the 
presence of the 4.l-like 68/65-kD protein as the major protein in this peak. 
Protein standards of 3.7-S G-actin (58), 5-S transferrin, and ll-S tetrameric 
fodrin or spectrin (32) were used to determine the S value of the iodinated 
peak. 
Reassociation of  Lymphoma 4.l-like Protein with  gp 25 
(Thy-l) Molecules 
Upon removal  of 2  M  urea,  these unlabeled  or  t25I-labeled  lymphoma 
4.l-like proteins (4-S material, 68/65-kD protein prepared according to the 
same procedures described above) were then incubated with t2~I-labeled 
and unlabeled Thy-1 molecules (prepared according to the procedures out- 
lined by Williams et al. [69]), respectively for 2 h in 20 mM KCI, 10 mM 
Tris-HC1,  pH 8.0, 0.5%  NP-40 at approximately equal molar concentra- 
tions.  The  resulting complex was  then analyzed by  a  sucrose gradient 
(7-48%)  centrifugation as described above or passing over coneanavalin 
A-Sepharose columns (6.0 x  0.5 cm) equilibrated with 20 mM KC1, 10 mM 
Tris-HCl, pH 8.0, containing 0.5% NP-40.  After binding, the columns were 
washed with equilibration buffer until no more radioactivity was removed. 
After washing, columns were elated with 1 M Q-methyl-o-mannoside and 
0.5-ml fractions were collected. A parallel concanavalin A-Sepharose col- 
umn was run as a control for the nonspeciflc binding and/or elution of t25I- 
labeled lymphoma 4.1. Fractions from all columns were then counted and 
plotted vs. fraction number to establish an elution profile for each column. 
Peak fractions from each column were then processed through anti-Thy- 
1-conjugated  immunobead  columns  (as  described  in  the  immunobead- 
binding section). 
Actin-binding Analysis 
[35S]Methionine-labeled  28-S complex material was either preincubated in 
the presence or absence of  0.1 p.M of bovine brain fodrin (prepared accord- 
ing to Bennett et at. [9]) in phosphate-buffered  Earle's balanced salt solution 
for 2 h and then added to 4.65 I~M G-actin under polymerizing conditions 
for 2  h. After 2  h, the material was centrifuged at 20000 g~ for 20 min 
and assayed for binding by determining the amount of [35S]methionine  la- 
bel that became associated with the actin pellets (54). Controls were carried 
out to determine the amount of the 28-S material that would pellet in the 
absence of fodrin and actin. 
Fodrin (or Spectrin) Binding Assays 
Bovine brain fodrin (or human erythrocyte spectrin) (9,  18) and BSA were 
each  conjugated  to  CNBr-activated  Sepharose  beads  (Pharmacia  Fine 
Chemicals).  t2SI-labeled  lymphoma proteins  (either  the 28-S  Thy-1/4.1 
complex, 68t65-kD [4-S material], or Thy-1) were then incubated with 200 
btl of either fodrin or BSA-conjugated beads overnight at 0°C in phosphate- 
buffered  Earle's  balanced  salt  solution.  After  binding,  the  beads  were 
washed extensively with phosphate-buffered Earle's balanced salt solution 
and then the amount of binding was assayed by gamma counting. 
Results 
Identification of Thy-1 Antigen and Its Associated 
Cytoskeletal Proteins 
To analyze the major membrane components in the mouse 
T-lymphoma cell line (BW 5147),  cells were either metaboli- 
cally labeled with [3H]glucosamine or surface-labeled with 
~zsI. SDS PAGE and autoradiographic  analysis indicates that 
gp 180 (180 kD), gp 85 (85 kD), and gp 25 (25 kD) are three 
major glycoproteins in the plasma membrane fraction (Fig. 
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minant is borne on a glycoprotein of •25,000  D in the mouse 
T-lymphoma cell line (BW 5147) (64).  This glycoprotein has 
been isolated from cultured mouse T-lymphoma cell lines 
and used to prepare either polyclonal or monoclonal antisera 
which show a  strong cross-reactivity to gp 25  (Fig.  1 B). 
Control experiments using anti-Thy-l-free serum reveal no 
detectable gp 25 (Fig. 1 C) confirming the specificity of this 
immunoprecipitation data. 
The availability of anti-Thy-1 antiserum has allowed us to 
examine Thy-1 (gp 25) patching and capping cytochemically 
(Fig.  1 D). Treatment of the lymphoma cells with only the 
primary antibody (monoclonal rat anti-Thy-1  antibody) in- 
duces only 10-15 % capped ceils in the total lymphoma cells. 
The proportion of Thy-1 patched and capped cells  is  en- 
hanced to 50-60%  of the total population if the cells are 
treated with both primary and secondary antibodies (i.e., rat 
anti-Thy-1 antibody followed by goat anti-rat antibody) (Fig. 
1 D) (12). The Thy-1 patch and cap structures are always ac- 
companied by a localized concentration of intracellular actin 
and myosin directly under the surface patches and caps (13, 
17). Therefore, it has been suggested that the cytoskeleton is 
directly involved in Thy-1 patching and capping (13, 17). 
Association of CeU Surface Glycoproteins with the 
Detergent-insoluble Cytoskeleton 
One way to gain a better understanding of the interactions oc- 
curring between Thy-1 antigens and the cytoskeleton is to 
isolate and analyze the membrane-cytoskeleton complexes 
from  lymphoma cells.  Treatment  of  isolated  lymphoma 
plasma membrane (t25I-labeled) (Fig. 2, A and B) with the 
non-ionic detergent, NP-40, solubilizes ~90 % of total mem- 
brane proteins (Fig. 2, C and D) and leaves an insoluble resi- 
due  that can  be  pelleted  by  centrifugation at  100,000 gay 
(Fig. 2, E and F). Our data show that three major surface 
membrane proteins, gp 180, gp 85, and gp 25 (Fig. 2 F), are 
preferentially associated with the insoluble fraction which is 
operationally defined as the cytoskeleton fraction, since it 
contains  actin,  myosin,  fodrin,  and  ankyrin-like/72-kD 
molecules (Fig. 2 E).  Recently, we have reported that both 
gp  180  and gp  85  (via  an ankyrin-like molecule) can be 
linked to the cytoskeletal protein, fodrin (16, 18). The nature 
of the linkage between gp 25  (Thy-1) and the cytoskeleton, 
however,  has not been defined clearly. 
Identification of the 68/65-kD Doublet as a 
4.l-like Protein 
Nonerythroid 4.l-like proteins (ranging in molecular mass 
from 68,000  to 80,000  D)  have been  identified in several 
different cell types (5, 23,  33, 34, 62).  It has been demon- 
strated  that  at  least  one  of these  non-erythroid 4.l-like 
molecules can be phosphorylated by a cAMP-dependent ki- 
nase (6,  38,  50,  60).  Fig.  3  shows the results of our SDS 
PAGE and autoradiographic analysis of the phosphoprotein 
components found in both the total plasma membrane and 
cytoskeletal fractions (i.e.,  NP-40-insoluble material) iso- 
lated from lymphoma cells that were briefly labeled with 
H332po4.  The 68/65-kD  polypeptide doublet is detected in 
the total plasma membrane (Fig.  3 A) and the cytoskeletal 
fractions  (Fig.  3  B).  The  membrane-cytoskeleton phos- 
phoprotein of 130 kD has been previously identified as myo- 
Figure 3. Identification  of lymphoma phosphoproteins. (A) Autora- 
diogram of H332po4-1abeled proteins in the total plasma mem- 
brane. (B) Autoradiogram of H332PO4-1abeled proteins associated 
with the NP-40-insoluble fraction (i.e., cytoskeleton material) of 
the plasma membrane. MLCK, myosin light chain kinase (14). 
sin light chain kinase (Fig. 3, A and B) (14). We have now 
identified the 68/65-kD  polypeptide doublet in the mem- 
brane-cytoskeletal fraction as a phosphorylated lymphoma 
4.l-like  protein  by  a  standard immunoprecipitation tech- 
nique (Fig. 4 C) using an antibody shown to be specific for 
erythrocyte band 4.1  by immunoblotting (Fig.  4  B).  The 
specificity of the immunoreagent was demonstrated by the 
fact that (a) anti-erythrocyte band 4.1 recognizes only band 
4.1  (82,000/78,000  D) in human erythrocyte ghosts (Fig. 4 
B);  and (b)  an anti-4.1-free antiserum (i.e.,  preabsorbed 
with purified erythrocyte 4.1 [Fig. 4 A]) precipitated neither 
the  68/65-kD  polypeptide  nor  any  of  the  other  phos- 
phorylated proteins (Fig. 4 D). Therefore, we propose that 
the 68/65-kD protein doublet is an immunoreactive form of 
the erythrocyte band 4.1 found in mouse T-lymphoma cells. 
In addition, we have found that the level of phosphoryla- 
tion of the 4.l-like protein doublet (along with the 130,000-D 
and 85,000-D  proteins but not the 45,000-D  and 36,000-D 
proteins)  is  significantly  enhanced  during  phorbol  ester 
(TPA) treatment (Fig. 5, A and B). Furthermore, the results 
of our phosphoamino acid analysis indicate that phosphory- 
lation of the lymphoma 4.l-like protein occurs primarily at 
serine residues (with very little in threonine and none in tyro- 
sine residues) in both TPA-treated  (Fig. 6, a and b) and un- 
treated control samples (Fig.  6,  c and d).  In vitro protein 
phosphorylation experiments using  [~/-32P]ATP reveal  that 
the phosphorylation of the 4.l-like protein occurs in the pres- 
ence of Ca  2÷ (10-4-10  -6 M [pCa=4.0-6.0]), but is greatly di- 
minished in the absence of Ca  2÷ (10  -8 M [pCa=8.0]) (Fig. 5, 
C and D). Therefore, we believe that the phorbol ester-acti- 
vated protein kinase C may be responsible for the phosphory- 
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acterization  of lymphoma 4. l- 
like protein.  Cells were either 
metabolically  labeled  with 
carrier-free H332po4 (C  and 
D)  or  surface  labeled  with 
125I (E and F) as described  in 
Materials  and  Methods.  (A) 
Purified  erythrocyte band 4.1 
resolved  into  4.1a  and  4.lb 
subunits on a  12% SDS poly- 
acrylamide gel.  (B) Immuno- 
blot oferythrocyte ghost mem- 
branes using erythrocyte anti- 
4.1  antibody.  (In order to re- 
solve a wide range of  polypep- 
tides,  the  ghost  membranes 
were analyzed by a 6.0-17.0  % 
SDS polyacrylamide gradient 
gel.  Under  these  conditions 
the 4.1  protein  resolves  as a 
single band.) (C and E) Auto- 
radiogram  of  either  32p-la- 
beled  proteins  (C) or surface 
~2sI-iabeled protein  (E)  that 
can be specifically immunoprecipitated  by anti-erythrocyte band 4.1 antibody from NP-40-extracted plasma membrane.  (D and F) Autora- 
diogram of either 32p-labeled proteins  (D) or surface  ~25I-labeled proteins  (F) that can be precipitated  by anti-erythrocyte band 4.1-free 
(preabsorbed  with purified  band 4.1 in A) antisera  from NP-40-extracted plasma membrane.  (Note that neither  68/65-kD nor gp 25 are 
detected in D and F.) (a and b) Double immunofluorescence  staining of lymphoma cells for localization of cell surface Thy-1 cap structures 
(a) and intracellular  lymphoma 4.l-like proteins  (b).  Bar,  13 I.tm. 
lation of the lymphoma 4.l-like protein (primarily at serine 
residues)  (Fig.  6)  in a  manner similar to that described  in 
erythrocytes (29). 
Structural Linkage between the Thy-1 Antigen and the 
4.l-like Protein 
Double-label  immunofluorescence staining  shows that dur- 
ing Thy-1 capping (Fig. 4 a), a 4.l-like protein concentrates 
directly beneath the Thy-1 cap structures (Fig. 4 b). This pro- 
vides qualitative evidence for the co-redistribution of these 
two molecules during capping. To demonstrate the possible 
linkages between these two molecules, we analyzed plasma 
membrane extracts by immunoprecipitation.  The immuno- 
precipitation of ~25I-labeled plasma membrane with anti-4.1 
antibody reveals  the co-precipitation of gp 25  (Thy-1  anti- 
gen), but not gp 180 or gp 85 (Fig. 4 E). In the presence of 
anti-4.1-free antiserum,  no surface molecules are detected 
(Fig. 4 F). These data strongly suggest that there is a close 
association between 4.l-like molecules and the Thy-1 capped 
structures. 
We have used sucrose gradient centrifugation in order to 
further analyze the nature of the linkage between gp 25 (Thy- 
1)  and  the  4.l-like  molecule.  This  approach  has  recently 
been  found  to  be  very  effective  in  the  isolation  of mem- 
brane-cytoskeleton complexes from lymphoma cells (16, 18). 
Centrifugation  of the  non-ionic detergent  (NP-40)-solubi- 
lized lymphoma plasma membrane fraction (material contain- 
ing either [35S]methionine-labeled [Fig. 7; curve 1],  [3H]glu- 
cosamine-labeled  [Fig.  7,  curve  2],  or  J25I-labeled  gp  25 
[determined by calculating the relative proportion ofgp 25 to 
other surface  ~25I-labeled proteins across the gradient;  Fig. 
7,  curve 3])  indicates  that the  majority  of the  membrane- 
associated components remain near the top of the gradient 
(Fig.  7).  In contrast,  a  very large proportion of 125I-labeled 
gp 25 is detected in the middle of the gradient with an esti- 
mated  S  value  of 28  (Fig.  7,  curve  3).  Svedberg  units  of 
sedimentation  coefficients were determined  relative to  ll-S 
tetrameric  spectrin or fodrin (32) and  18-S apoferritin  (61) 
that were used as sedimentation markers. SDS PAGE and au- 
Figure 5. Phosphorylation of lymphoma proteins  in the presence of 
TPA  or  Ca  2÷.  (A  and  B)  Autoradiogram of 32p-labeled plasma 
membrane isolated from cells that were metabolically  labeled with 
carrier-free  H3PO4 in the presence (B) or absence (A) of phorbol 
ester,  TPA.  (C and D) Autoradiogram of plasma membrane that 
was  incubated  with  ['/-32p]ATP in  vitro  in the  presence of Ca  2÷ 
(10-4-10  -6 M) (O) or absence of Ca  2÷ (10  -~ M) (C). 
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acids  of  the  68/65-kD  protein  from 
H332po4-1abeled cells  treated  with  or 
without  TPA. The acid  hydrolysate of 
32p-labeled 68/65-kD  protein  isolated 
from ceils that were labeled either in the 
presence (a and b) or absence of TPA (c 
and d) was resolved in two dimensions 
by electrophoresis as described in Mate- 
rials  and  Methods.  The  P-ser,  P-thre, 
P-tyr standards  (a and c;  identified by 
ninhydrin  staining) were  mixed  with 
32p-labeled samples prepared from TPA- 
treated cells (b; autoradiogram) and un- 
treated cells (d; autoradiogram),  respec- 
tively. (a and b are the same sample; c 
and d are the same sample. The origin 
is designated by an arrow. P-ser, phos- 
phoserine;  P-thre,  phosphothreonine; 
and P-tyr, phosphotyrosine.) 
toradiographic  analysis  of the  pooled  fractions  from  the 
[35S]methionine-labeled 28-S region (fraction numbers  16- 
20) reveals the presence of only a 68/65-kD doublet and the 
gp 25  (Thy-1) antigen (Fig. 7, lane 1).  Similar results were 
obtained after identical analysis with ~25I-labeled total cellu- 
lar  extracts  (data  not  shown).  Autoradiograms  of  either 
~25I-surface  labeled  or  [3H]glucosamine-labeled  material 
demonstrate that gp 25 is the only surface-labeled glycopro- 
tein present in the 28-S peak (Fig.  7,  lanes 2  and 3). 
The molar ratio of the 68/65-kD (4.i-like) protein and gp 
25  (Thy-1)  in  the 28-S  complex has  been examined using 
autoradiograms of either  ~2SI-labeled or [3~S]methionine-la- 
beled 28-S material (i.e., Fig. 7, lane 1 ). The ratio of 68/65- 
kD protein to gp 25 was determined by integration of the area 
under the respective peaks generated by scanning densitome- 
try of the autoradiograms (Fig. 8). For our calculations, we 
assumed a monomeric form of each subunit of the 68/65-kD 
protein  (68,000-65,000  D  per  subunit)  and  a  monomeric 
form of gp 25 (25,000 D). We also assumed equivalent label- 
ing  with  either  125I or  [35S]methionine  for  both  polypep- 
tides,  since identical ratios of 68/65-kD to gp 25 were ob- 
tained  with  both isotopes.  These preliminary  calculations 
show that the 68/65-kD protein and gp 25 (Thy-1) occur in 
a  stoichiometric ratio of ,-o1:4. 
Bourguignon et al.  Thy-1 Glycoprotein la'nked to 4.l-like Protein  2535 Figure  7.  Sucrose  gradient  centrifugation  of NP-40-solubilized  plasma  membranes.  Cells  were  metabolically  labeled  with  either 
[35S]methionine or [3H]glucosamine,  or surface labeled with  125I. Radioactively labeled plasma membranes were isolated,  extracted by 
NP-40 followed by centrifugation on a  7-48%  sucrose gradient  as described  in Materials  and Methods.  (Curve  1)  [35S]methionine- 
labeled plasma membrane protein profile.  (Curve 2)  [3H]glucosamine-labeled glycoprotein profile.  (Curve 3)  Relative amount of 1251- 
surface labeled gp 25 (Thy-1) across the gradient (determined by calculating the relative proportion of gp 25 to other surface 125I-labeled 
proteins). Protein standards used are tetrameric spectrin or fodrin,  11 S; and apoferritin,  18 S.  (Lane 1)  Autoradiogram of [35S]methio- 
nine-labeled proteins detected in 28-S peak. (A similar pattern was obtained using ~5I-labeled total cellular proteins.) (Lane 2) Autoradio- 
gram of [3H]glucosamine-labeled proteins detected in 28-S peak. (Lane 3)  Autoradiogram of ~25I-labeled surface proteins detected in the 
28-S peak. 
Treatment  of the  28-S  complex material  with  2  M  urea 
results in the disruption of the 28-S complex and the release 
of the 68/65-kD doublet with a Svedberg unit of sedimenta- 
tion  coefficient  of 4  S  (Fig.  9,  A  and  B)  (G-actin  [3.7  S], 
transferrin  [5.0 S], and tetrameric fodrin [11 S] were used as 
standard sedimentation markers [32,  58]).  A  large majority 
of the  4-S  material  can  be  immunoprecipitated  with  anti- 
erythrocyte  band  4.1  antibody  (Fig.  9,  C  and  D).  Upon 
removal of 2  M  urea,  the lymphoma 4.l-like  protein (4 S; 
68/65-kD  doublet)  is  capable  of reassociating  with  Thy-I 
molecules as a 28-S complex (data not shown). The resulting 
complex is capable of binding to a concanavalin A-sepharose 
column and both Thy-1 and 4.l-like  material coelute in the 
presence of ct-methyl-o-mannoside (Fig.  10 A). In addition, 
the  Thy-1/4.1  reassociated  material  can  be  quantitatively 
precipitated by anti-Thy-1 antibody (Fig.  10 B),  confirming 
that both  the  Thy-1  and  4.l-like  polypeptides  form a  rela- 
tively stable  complex.  Therefore,  we believe that the lym- 
phoma 4.l-like protein (4S-68/65-kD  molecule) and Thy-1 
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Figure 8. Analysis of molar ratio between the 68/65-kD protein and 
gp 25 in the 28-S complex. The 28-S complex labeled with 12sI or 
[35S]methionine was obtained  according to the procedures described 
in Fig.  7.  Autoradiograms of the radioactively labeled 28-S com- 
plex, analyzed by SDS PAGE, were scanned on a scanning densi- 
tometer. The preliminary calculations of the stoichiometry between 
the 68/65-kD protein and gp 25 is 1:4. This value was determined 
by scanning  autoradiograms of either  t25I- or  [35S]methionine-la- 
beled material. We assumed a monomeric form of each subunit of 
the 68/65-kD protein (68,000  D/per subunit),  a monomeric form 
of gp 25 (Thy-1) (25,000  D), and equivalent labeling of these pro- 
teins with  1251 or [35S]methionine. 
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protein,  (A)  First,  t25I-labeled 28-S  complex 
was isolated according to the procedures de- 
scribed  in  Materials  and  Methods  and  then 
treated with 2  M  urea.  The urea-soluble ma- 
terial  was  loaded  on  a  linear  sucrose  gradi- 
ent (%28%) and centrifuged at 70,000 g,v for 
22  h.  Protein  standards  of  G-actin  (3.7 S), 
transferrin (5.0 S), and tetrameric spectrin or 
fodrin (11 S) were used to estimate the S value 
of the ~25I-labeled peak as 4 S. (B) Autoradio- 
gram of the  125I-labeled  4-S material (primar- 
ily 68/65-kD protein). (C and D) Histogram of 
immunoprecipitation  data  of  t25-1abeled 4-S 
material  (primarily  68/65-kD  protein)  that 
specifically reacted  with  rabbit  anti-erythro- 
cyte band 4.1  (C)  or  rabbit anti-erythrocyte 
band  4.1-free  (preabsorbed)  antiserum  (D). 
(Note that a large amount of the 4-S material 
can  be  immunoprecipitated  by anti--4.1  anti- 
body [C] with very little nonspecific precipita- 
tion [DI). 
Interaction between the Lymphoma 4.l-like Protein 
and Fodrin (or Spectrin ) 
Since previous studies have suggested that the Thy-1 antigen 
(gp  25)  becomes  associated  with  the  NP-40-insoluble  cy- 
toskeleton  in  mouse  T-lymphoma during  receptor  capping 
(16), we have conducted F-actin-binding assays to determine 
if the isolated 28-S (Thy-1/4.1 complex) material has the abil- 
ity  to bind  F-actin  filaments  in vitro.  When  28-S  complex 
material was incubated with actin in the absence of fodrin (or 
spectrin),  no  binding  with  F-actin  was  observed  (data  not 
shown).  However, when the 28-S complex was preincubated 
with fodrin and then assayed for actin binding,  it displayed 
a significant binding capability for F-actin filaments (data not 
shown).  This set of data suggests that the Thy-1/4.1 complex 
can  bind  to  actin  through  its  interaction  with  the  actin- 
binding protein,  fodrin.  To test this hypothesis  directly,  we 
isolated the 28-S  complex,  urea-extracted  to dissociate  the 
4.l-like (4 S-68/65-kD protein) doublet from the Thy-1 (gp 
25)  and  then  assayed  for binding  to  fodrin  (or  spectrin)- 
conjugated  Sepharose  beads  (Fig.  ll,  A  and B).  BSA-con- 
jugated beads were used as a control for the nonspecific ad- 
herence of the isolated proteins to protein-conjugated beads. 
Our data demonstrate that the 28-S complex material has the 
ability to bind  directly  to fodrin-  (or spectrin-)  conjugated 
beads (Fig.  11  C).  The fact that fodrin binding  is mediated 
through  the  lymphoma 4.l-like  protein  is demonstrated  by 
the high level of binding between fodrin (or spectrin) and the 
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Figure 10. Reassociation of Thy-l/4.1  complex. 
(A) After the removal of 2 M urea, 125I-labeled 
(open circles) or unlabeled lymphoma 4.l-like 
protein  (4-S  material,  68/65-kD  protein)  (as 
shown  in  Fig.  9)  was  incubated  with  an un- 
labeled  or  ~25I-labeled (solid  circles)  Thy-1, 
respectively, according to the procedures de- 
scribed in  Materials  and  Methods.  The reas- 
sociated Thy-l/4.1  complex can be co-bound to 
a concanavalin A-Sepharose column followed 
by  co-elution  with  a-methyl-D-mannoside 
(a-MDM)  (solid  and  open  circles).  °SI-la- 
beled 4.l-like protein alone (without  incuba- 
tion with Thy-1) fails to bind and/or specifically 
be  eluted  from a  concanavalin  A-Sepharose 
column (solid squares).  (B) The ct-methyl-o- 
mannoside-eluted  material  was  subsequently 
processed  through  immunoatfinity  columns 
conjugated  with  either  monoclonal  rat 
anti-Thy-1  antibody or anti-Thy-l-free (preab- 
sorbed)  serum.  (a)  125I-Thy-1/4.1 complex 
bound  to an anti-Thy-I  column.  (b)  ~25I-Thy- 
1/4.1  complex  bound  to  an  anti-Thy-l-free 
(control)  column.  (c)  Thy-l/~25I-4.1 complex 
bound to an anti-Thy-1  column. (d) Thy-1/125I  - 
4.1 complex bound to an anti-Thy-l-free (con- 
trol) column. 
Bourguignon et al. Thy-1 Glycoprotein  Linked to 4. l-like Protein  2537 Figure  11.  Direct  binding of 
lymphoma proteins  (i.e.,  28 
S, 68/65-kD protein, and Thy- 
1 [gp 25]) to fodrin- (or spec- 
trin-)  conjugated  Sepharose 
beads.  125I- or  [35S]methio- 
nine-labeled proteins (i.e., 28 
S, the 68/65-kD protein, and 
Thy-1 [gp 25]) were incubated 
with  fodrin-  (A)  (hatched 
bars) or spectrin- (B) or BSA- 
(as a control) (solid bars) con- 
jugated Sepharose beads. The 
radioactivity  associated  with 
the  fodrin-conjugated  beads 
was determined by either gam- 
ma  (~25I) or  liquid scintilla- 
tion  ([35S]methionine) count- 
ing.  Similar  findings were 
observed using  spectrin-con- 
jugated beads. 
to the insignificant amount of binding  between fodrin (or 
spectrin) and isolated Thy-1  (Fig.  11). We believe that this 
fodrin- (or spectrin-) binding assay is specific, since there is 
only a  minimal amount of nonspecific binding of isolated 
lymphoma proteins (i.e. 68/65 kD, 28 S, or Thy-1) to BSA- 
conjugated Sepharose beads. 
Discussion 
It has been well established that actomyosin-containing com- 
ponents are closely associated with lymphocyte receptor patch 
and cap structures (11, 12).  Recently, analogs of the eryth- 
rocyte membrane-cytoskeleton proteins,  such  as  spectrin, 
ankyrin, and protein 4.1, have also been detected in lympho- 
cytes (12, 16,  18, 42, 48).  Most important, lymphocyte sur- 
face membranes appear to be selectively associated with the 
immunoreactive forms of spectrin (so-called fodrin), anky- 
rin, and protein 4.1, all of which co-cap with surface receptor 
cap structures (11, 12,  16,  18, 42, 48). 
Recently, we have found that two lymphocyte transmem- 
brane glycoproteins, gp 180 and gp 85, are closely associated 
with fodrin and ankyrin-like proteins, respectively (16, 18). 
Specifically, we have demonstrated that gp 180 (a transmem- 
brane glycoprotein) is preferentially associated with fodrin, 
in a  1:1 molar ratio (16). Another lymphoma glycoprotein, 
gp 85, is tightly bound to an ankyrin-like protein in a stable 
complex  that  resembles  the  erythrocyte band  3-ankyrin 
complex (18). Furthermore, this gp 85-ankyrin complex is 
capable of binding  the  actin-binding  protein,  fodrin  (18). 
Therefore, the functional involvement of fodrin in linking the 
lymphoma gtycoprotein (gp 180 and gp 85/ankyrin-like com- 
plex) to actin filaments is strongly implicated. 
As part of our continued interest in exploring the trans- 
membrane interactions which occur between surface recep- 
tor  molecules and  the  cytoskeleton,  we  have  investigated 
whether  there  is  a  4.l-like  protein  in  lymphoma  mem- 
brane-cytoskeleton preparations.  Previously, immunoreac- 
tive forms of protein 4.1 have been detected in several differ- 
ent cell types including lymphocytes (62). Spiegel et al. (62) 
reported that in  lymphocytes the immunoreactive form of 
protein 4.1 appears as a 68,000-D protein by SDS PAGE, im- 
munoblotting,  and  autoradiographic  techniques.  Our  im- 
munoprecipitation experiments using a specific erythrocyte 
4.1  antibody followed by SDS PAGE and autoradiographic 
analysis reveals that the lymphoma 4.l-like protein consists 
of a doublet of 68,000 and 65,000 D. It is not surprising to 
find a 4.l-like protein in lymphocytes that differs in molecu- 
lar mass from the erythrocyte  band 4.1. Molecular mass vari- 
ants have been observed in a number of different cell types 
of both erythroid and non-erythroid origin (5,  23,  33,  34, 
62). These variations clearly do not necessarily reflect differ- 
ences in 4.1 function since all of the different molecular mass 
forms still retain their ability to bind spectrin or fodrin (6). 
The lymphoma 4.l-like protein represents a component of 
the insoluble cytoskeletal fraction of lymphoma membranes 
prepared by non-ionic detergent (NP-40) extraction (Figs. 3 
and 4). This 4.l-like protein can be phosphorylated either by 
metabolically labeling cells with H332po4 (Figs. 3, A and B; 
4 A; and 5, A and B) or by labeling isolated plasma mem- 
brane with ['f-32P]ATP in vitro in the presence of Ca  2÷ (Fig. 
5 D) (but not in the absence of Ca  2÷ [Fig.  5  C]).  The re- 
quirement of Ca  2÷ for phosphorylation suggests the possi- 
bility that the enzyme, protein kinase C, might be involved 
in this phosphorylation reaction. 
Recently, Eder et al.  (29) have reported that erythrocyte 
membrane kinases and casein kinase A phosphorylate eryth- 
rocyte band 4.1  on both serine and threonine residues. Our 
phosphoamino acid analysis indicates that lymphoma 4.l- 
like protein is phosphorylated at serine residues (very little 
phosphorylation can be detected in  threonine and none in 
tyrosine residues)  (Fig.  6).  This observation suggests  that 
the lymphoma 4.l-like protein might share homology with 
erythrocyte band 4.1  serving as a  substrate for protein ki- 
nase(s) (6,  38, 50,  60). At this time, the regulatory mecha- 
nism involved in the phosphorylation of this 4.l-like protein 
is unknown. 
Phorbol esters such as TPA are known to stimulate a num- 
ber of biological activities at nanomolar concentrations (28, 
47). There is good evidence that phorbol esters can directly 
activate protein kinase C, an enzyme that normally requires 
both phospholipid and calcium for its activity (4, 49, 50, 51, 
63). It is known that protein kinase C is activated specifically by 
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tion of phosphatidylinositol turnover (63). In vitro, TPA can 
substitute for diacylglycerol and directly activate protein ki- 
nase C  in the presence of both Ca  2÷ and phospholipid (4, 
49,  50,  63).  Recently, it has been reported that the phos- 
phorylation of band 4.1 in intact erythrocytes is stimulated 
by phorbol ester, suggesting the possible involvement of pro- 
tein kinase C in the phosphorylation of erythrocyte band 4.1 
(43). The observations that (a) phorbol ester (TPA) enhances 
the phosphorylation of lymphoma 4.l-like protein (Fig. 5, A 
and B) on serine residues (Fig. 6, a-d), and (b) phosphoryla- 
tion of the lymphoma 4.l-like protein requires the presence 
of Ca  2÷, in vitro, strongly suggest that the lymphoma 4.l- 
like protein is a substrate for protein kinase C. 
Recent studies in erythrocytes indicate that the band 4.1, 
in addition to being a spectrin-binding protein, may also in- 
teract  directly  with  the  erythrocyte membrane  after  the 
removal of peripheral membrane proteins (1, 53, 59). At least 
two membrane-binding sites for 4.1 have been identified: a 
high affinity site on glycophorin A (1), and a low affinity site 
associated with band 3 (53). Interestingly, the association be- 
tween glycophorin and protein 4.1 appears to be regulated by 
polyphosphoinositides (2). Studies done with phosphatidyl- 
serine-containing liposomes have also led to the speculation 
that phospholipid domains alone could serve as an alterna- 
tive anchoring site for 4.1, as well as other cytoskeletal pro- 
teins (56). 
The Thy-1 alloantigenic determinant is a glycoprotein of 
25,000 D which, in the mouse, has been termed T-25 (desig- 
nated as gp 25 in this paper). Both thymocyte  and brain Thy-1 
glycoproteins display hydrophobic properties which may be 
responsible for their binding to the plasma membrane (69). 
However,  the  initial determination of the  sequence of rat 
brain Thy-1 glycoprotein failed to detect the presence of a 
hydrophobic segment (20).  This has prompted speculation 
that Thy-1 insertion into the lipid bilayer may be through 
some hydrophobic components such as a phosphatidylinosi- 
tol-like molecule that would link the Thy-1 glycoprotein to 
the membrane (44).  Recently, DNA sequence analysis has 
revealed a 31-amino acid hydrophobic segment that may be 
important for the integration of the Thy-1 molecule into the 
plasma membrane (21, 57).  Like purified glycophorin (31), 
purified Thy-1 antigen exists as an aggregate of 10-14 Thy-1 
monomers (69).  This aggregated form of Thy-I (gp 25) may 
represent  pre-existing natural clusters of receptors  in the 
plane of the membrane. 
In this  study, using complementary techniques such as 
double-label immunofluorescence staining (Fig. 4, a and b), 
immunoprecipitation (Fig.  4,  A-D),  and sucrose gradient 
centrifugation (Fig. 7),  we have established that a 4.l-like 
protein is closely associated with gp 25 (Thy-1 antigen) in the 
form of a 28-S  complex with a  stoichiometric ratio of 1:4 
(Fig. 8). The fact that we are able to dissociate and then reas- 
sociate the 4.l-like protein and Thy-1 molecule, by adding 
and then removing 2 M urea (Figs. 9 and 10), suggests that 
these two proteins specifically interact with each other. Since 
the binding domain of Thy-1 to the 4.l-like protein has not 
been determined,  we do not preclude the possibility that 
there may be other minor components (either lipid or protein 
molecules) responsible for linking the Thy-1 antigen to the 
4.l-like protein in lymphoma membranes. Further analysis 
of the interactions between the lymphoma 4.l-like protein 
and other transmembrane glycoproteins is currently under 
investigation in our laboratory. 
Most importantly, we have determined that the Thy-1/4.1- 
like protein complex is capable of interacting with actin fila- 
ments via fodrin or spectrin (data not shown). This property 
is one of the best-known characteristics of erythrocyte pro- 
tein  4.1  that  is  known  to  be  a  spectrin-binding  protein 
(66-68). Further analysis using a fodrin- (or spectrin-) bind- 
ing assay confirms that the lymphoma 4.l-like protein (not 
the Thy-1 antigen) is responsible for the binding of the com- 
plex to fodrin or spectrin (Fig.  11). 
Our evidence for identifying the 68/65-kD  doublet as a 
4.l-like protein is summarized as follows: (a) it displays an 
immunological cross-reactivity with anti-erythrocyte band 
4.1 antibody; (b) it exhibits a Svedberg unit of sedimentation 
coefficient of 4 S; (c) it can be readily phosphorylated in the 
presence of TPA and Ca  2÷ (but not in the absence of Ca2÷); 
(d) its major sites for phosphorylation are on serine residues; 
and (e) it can interact directly with fodrin. In conclusion, we 
believe our data clearly support the notion that certain linker 
molecules (e.g., 4.l-like and ankyrin-like proteins) as well 
as fodrin play a  pivotal role in linking surface membrane 
receptors to the intracellular actin-containing microfilament 
network whose contraction is required for receptor capping. 
We  are  grateful  to  Dr.  Gerard  J.  Bourguignon (University  of Miami) 
for his assistance in the preparation of this manuscript. We would also like 
to  thank  Dr.  William  Kinsey  (University of Miami)  for his expert as- 
sistance in the phosphoamino  acid analysis and Dr. Van Bennett (The Johns 
Hopkins University,  Baltimore,  MD)  for his generous supply of rabbit 
anti-erythrocyte band 4.1  antibody. 
This work was supported by National  Institutes of Health grants AI 19188, 
GM 36353,  ACS (F 86  UM-3), and American Heart Association grants. 
L. Y. W. Bourguignon is an Established  Investigator  of the American Heart 
Association. 
Received for publication  25 June 1986, and in revised form 19 August 1986. 
References 
1. Anderson,  R.  A., and R.  E.  Lovrien.  1984. Glycophorin  is linked by 
band 4.1 protein to the human erythrocyte membrane skeleton. Nature (Lond.). 
307:655-658. 
2. Anderson, R. A., and V. T. Marchesi.  1985. Regulation of the associa- 
tion of membrane skeletal protein 4.1 with glycophorin by a polyphosphoinosi- 
tide. Nature  (Lond.).  318:295-298. 
3. Arndt,  R., R. Stark, and H. G. Thiele.  1977. Detection and molecular 
characterization  of the  thymus-brain  antigen  in human  brain.  Immunology. 
33:101-107. 
4.  Ashendel, C. L., J. M. Staller, and R. K. Boutwell. 1983. Identification 
of a calcium and phospholipid-dependent phorbol ester-binding  activity in the 
soluble fraction of mouse tissue. Biochem.  Biophys.  Res.  Commun.  111:340- 
345. 
5. Aster, J. C., G. J. Brewer,  S. M. Hanash,  and H. Maisel.  1984. Band 
4.l-like proteins of the bovine lens.  Biochem.  J.  224:609-616. 
6. Baines, A. J., and V. Bennett. 1985. Synapsin I is a spectrin-binding pro- 
tein immunologically related to erythrocyte protein 4.1.  Nature (Lond.).  315: 
410-413. 
7. Beech, J. N., R. J. Morris, and G. Raisman.  1983. Density of Thy-I on 
axonal membrane of different rat nerves J.  Neurochem.  41:411--417. 
8. Bennett, V. 1985. The membrane skeleton of human erythrocytes and its 
implications for more complex cells. Annu.  Rev.  Biochem.  54:273-304. 
9. Bennett,  V.,  J.  Davis,  and  W.  E.  Fowler.  1982. Brain  spectrin,  a 
membrane-associated protein  related in structure  and function to erythrocyte 
spectrin.  Nature  (Lond. ).  299:126-131. 
10.  Bonner,  W.  M., and  R.  A.  Laskey.  1974. Film detection method for 
tritium-labeled proteins and nucleic acids in polyacrylamide gels. Eur. J.  Bio- 
chem.  46:83-88. 
11. Bourguignon,  L.  Y. W.  1986. Ligand-induced surface receptor move- 
ment and transmembrane  interactions.  In Energetics of Secretory  Responses. 
J.  W.  N. Akkerman,  editor.  CRC  Press,  Inc. Boca Raton,  FL.  In press. 
12. Bourguignon, L. Y. W., and G. J. Bourguignon.  1984. Capping and the 
cytoskeleton.  Int.  Rev.  Cytol.  87:195-224. 
13.  Bourguignon, L. Y. W., and S. J. Singer. 1977. Transmembrane interac- 
Bourguignon et al.  Thy-I  Glycoprotein  Linked to 4. I-like Protein  2539 tions  and  the  mechanism  of capping  of surface  receptors  by their  specific 
ligands. Proc. Natl. Acad. Sci. USA. 74:5031-5035. 
14. Bourguignon,  L. Y. W., M.  L.  Nagpal, K. Balazovich, V. Guerriero, 
and A. R. Means.  1982. Association of myosin light chain kinase with lympho- 
cyte membrane-cytoskeleton  complex. J.  Cell Biol. 95:793-797. 
15. Bourguignon, L. Y. W., M. Nagpal, and Y. C. Hsing. 1981. Phosphory- 
lation of myosin light chain during capping of T-lymphoma cells. J.  Cell Biol. 
91:889-894. 
16.  Bourguignon, L. Y. W., S. J. Suchard, M. L. Nagpal, andJ. R. Glenney, 
Jr.  1985. A lymphoma transmembrane glycoprotein (gp 180) is linked to the 
cytoskeletal protein,  fodrin. J.  Cell Biol. 101:477--487. 
17.  Bourguignon, L. Y. W., T. Tokuyasu, and S. J. Singer.  1978. The cap- 
ping of lymphocytes and other cells,  studied by an improved method for im- 
munofluorescence staining of frozen sections. J.  Cell. Physiol.  95:239-258. 
18. Bourguignon,  L.  Y.  W.,  G.  Walker,  S.  Suchard,  and K. Balazovich. 
1986. A lymphoma plasma membrane-associated protein with an ankyrin-like 
properties.  J.  Cell Biol. 102:2115-2124. 
19. Butman, B. T., G. J. Bourguignon, and L. Y. W. Bourguignon.  1980. 
Lymphocyte  capping  induced by  polycationized  ferritin.  J.  Cell. Physiol. 
105:7-15. 
20. Campbell, D. G., J.  Gagnon, K. B. M. Reid, and A. F. Williams. Rat 
brain Thy-1 glycoprotein.  1981. Biochem. J.  195:15-30. 
21.  Chang, H-C., T. Moriuchi, R. Denome, H. Ploegh, andJ. Silver. 1985. 
A hydrophobic  transmembrane  segment at the carboxyl  terminus  of Thy-1. 
Science  (Wash. DC). 227:649-651. 
22. Cohen, C. M., and R. C. Langley.  1984. Functional characterization of 
human erythrocyte  spectrin alpha and beta chains:  association with actin and 
erythrocyte protein 4.1.  Biochemistry.  23:4488-4495. 
23. Cohen, C. M., S. F. Foley, and C. Korsgreu.  1982. A protein immuno- 
logically related to erythrocyte 4.1  is found on stress fibers on non-erythroid 
cells. Nature  (Lond.). 299:648-650. 
24.  Cohen,  F.  E., J.  Novotny,  M. J.  E.  Sternberg,  D. G.  Campbell,  and 
A. F. Williams.  1981. Analysis of structural similarities between brain Thy-1 
antigen and immunoglobulin domains. Biochem. J.  195:31-40. 
25.  Cooper, J. A., B. M. Sefton, and T. Hunter.  1983. Detection and quanti- 
tation of phosphotyrosine  in proteins.  Methods Enzymol.  99:387-402. 
26. Cuatrecasas, P. 1970. Protein purification by affinity chromatography. J. 
Biol.  Chem. 245:3059-3065. 
27.  Dalchau, R., and J. W. Fabre.  1979. Identification and unusual tissue dis- 
tribution  of the canine and human homologies of Thy-1. J.  Exp. Med. 149: 
576-591. 
28.  Dicker,  P.,  and  E.  Rozengurt.  1980. Phorbol  esters  and  vasopressin 
stimulate DNA synthesis by a common mechanism. Nature (Lond.). 287:607- 
612. 
29.  Eder,  P.  S., C. J.  Soong, and M. Tao.  1986. Phosphorylation reduces 
the affinity of protein 4.1  for spectrin.  Biochemistry.  25:1770-1776. 
30.  Fraker, P. J., and J. C. Speck. 1978. Protein and cell membrane iodina- 
tions with a sparingly soluble chloramide,  1,3,4,6-tetrachloro-3a,  6a-diphenyl- 
glycoluril.  Biochem,  Biophys. Res.  Commun. 80:849-857. 
31.  Furthmayer,  H., and V.  T.  Marchesi.  1983. Glycoproteins:  isolation, 
orientation,  and localization of specific domains. Methods Enzymol.  96:268- 
280. 
32. Glenney, J. R.,  P.  Glenney,  and K. Weber.  1982. F-actin binding and 
cross-linking properties of porcine brain fodrin, a spectrin-related molecule. J. 
Biol.  Chem. 257:9781-9787. 
33. Goodman,  S.  R.,  L.  Casoria,  D.  Coleman,  and  I.  S.  Zagon.  1984. 
Identification  and  location  of  brain  protein  4.1.  Science  (Wash. DC). 
224:1433-1435. 
34.  Granger, B. L., and E. Lazarides.  1984. Membrane skeletal protein 4.1 
of avian  erythrocytes  is  composed  of multiple  variants  that  exhibit  tissue- 
specific expression.  Cell. 37:595-607. 
35. Gunter, K. C., T. R. Malek, and E. M. Shevach. 1984. T-cell activating 
properties of an anti-Thy-1  monoclonal antibody possible analogy to OKT3/ 
Leu-4. J.  Exp. Med. 159:716-730. 
36.  Hunkapiller, M. W., E. Lujan, F. Ostrander, and L. E. Hood. 1983. Iso- 
lation of microgram quantities of proteins from polyacrylamide gels for amino 
acid sequence analysis.  Methods Enzymol.  91:227-236. 
37. Johnson, G. L., and H. R. Bourne.  1977. Influence of cholera toxin on 
the regulation of adenylate cyclase by GTP. Biochem. Biophys. Res. Commun. 
78:792-798. 
38. Johnson,  E.  M., T.  Ueda, H.  Maeno,  and P.  Greengard.  1972. Site- 
specific fluorescein-labeled cobra  or-toxin. J.  Biol. Chem. 257:5632-5636. 
39.  Laemmli, U. K. 1970. Cleavage of structural proteins during the assem- 
bly of the head of bacteriophage T-4. Nature  (Lond.).  227:680-685. 
40.  Laub, F., M. Kaplan, and C. Gitler.  1981. Actin polymerization accom- 
panies Thy-1 capping on mouse thymocytes. FEBS (Fed. Eur. Biochem. Soc.) 
Lett.  124:35-38. 
41.  Leifer,  D., S.  A. Lipton, C. J.  Barnstable, and R.  H. Masland.  1984. 
Monoclonal antibody to Thy-1 enhances regeneration of processes by rat retinal 
ganglion cells in culture.  Science  (Wash. DC). 224:303-306. 
42.  Levine, J., and M. Willard.  1983. Redistribution of fodrin (a component 
of the cortical  cytoplasm)  accompanying capping of cell surface molecules. 
Proc. Natl. Acad.  Sci. USA. 80:191-195. 
43.  Ling,  E., and V.  Sapirstein.  1984. Phorbol  ester  stimulates the phos- 
phorylation of rabbit erythrocyte band 4.1.  Biochem. Biophys. Res.  Commun. 
120:291-298. 
44.  Low,  M.  G.,  and  P.  W.  Kincade. 1985.  Phosphatidylinositol  is  the 
membrane-anchoring domain of the Thy- 1 glycoprotein. Nature (Lond.). 318: 
62-64. 
45. MacDonald,  H.  R.,  C.  Bron,  M.  Rousseanx,  C.  Horvath,  and J.  C. 
Cerottini.  1985. Production and characterization of monoclonal anti-Thy-1  an- 
tibodies that stimulate lymphokine production by cytolytic T-cell clones. Eur. 
J.  Immunol.  15:495-501. 
46. Maino, V. C., M. A. Norcross, M. S. Perkins, and R. T. Smith.  1981. 
Mechanism of Thy-1 mediated T-cell activation: roles of Fc receptors, T-200, 
Ia  and  H-2  glycoproteins  in  accessory  cell function.  J.  lmmunol.  126: 
1829-1836. 
47.  Mastro,  A.  M.  1983. Phorbol  ester tumor promoters  and lymphocyte 
proliferation.  Cell Biol. Int. Rep. 7:881-893. 
48.  Nelson, W. J., C. A. L. S. Colaco, and E. Lazarides.  1983. Involvement 
of spectrin in cell-surface receptor capping in lymphocytes. Proc. Natl. Acad. 
Sci.  USA. 80:1626-1630. 
49.  Niedel, J. E., L. J. Kuhn, and G. R. Vandenbark.  1983. Phorbol diester 
receptor  copurifies with protein  kinase C.  Proc. Natl. Acad. Sci. USA. 80: 
36--40. 
50.  Nishizuka, Y. 1983. Phospholipid degradation and signal translation for 
protein phosphorylation.  Trends Biochem. Sci. 8:13-16. 
51.  Nishizuka, Y.  1984. The role of protein kinase C in cell surface signal 
transduction and tumor promotion.  Nature  (Lond.).  308:693-698. 
52. Ohanian, V., L. C. Wolfe, K. W. John, V. C. Pinder,  S. E. Lux, and 
W. B. Gratzer.  1984. Analysis of ternary interaction of the red cell membrane 
skeletal proteins,  spectrin,  actin and 4.1.  Biochemistry.  23:4416-4420. 
53.  Pasternak, G., R. A. Anderson, T. L. Leto, and V. T. Marchesi.  1985. 
Interactions between protein 4.1 and band 3: an alternative binding site for an 
element of the membrane skeleton. J.  Biol. Chem. 260:3676-3683. 
54.  Pearl,  M.,  D.  Fishkind,  M.  Mooseker,  D.  Keene,  and T.  Keller Ill. 
1984. Studies on the spectrin-like protein from the intestinal brush border, TW 
260/240 and characterization of its interaction with the cytoskeleton and actin. 
J.  Cell Biol. 98:66-78. 
55. Reif, A. E., and J. M. V. Allen.  1964. The AKR thymic antigen and its 
distribution  in leukaemias and nervous tissues. J.  Exp. Med. 120:413-433. 
56.  Sato, S. B., and S. Ohnishi.  1983. Interaction of a peripheral protein of 
the erythrocyte membrane, band 4. l, with phosphatidylserine-containing lipo- 
somes and erythrocyte  inside-out vesicles. Eur. J.  Biochem.  130:19-25. 
57.  Seki, T., T. Moriuchi,  H.-C.  Chang, R. Denome, and J. Silver.  1985. 
Structural organization of the rat Thy-1 gene. Nature  (Lond.). 313:485-487. 
58.  Sheeler, P. 1981. In Centrifugation in Biology and Medical Science. John 
Wiley & Sons, Inc., New York.  p.  26. 
59. Shifter, K. A., and S.  R.  Goodman.  1984. Protein 4.1:  its association 
with  the  human  erythrocyte  membrane.  Proc. Natl. Acad.  Sci.  USA. 
81:4404-4408. 
60.  Siegfiart, W., J. Forn, and P. Greengard. Ca 2+ and cyclic AMP regulate 
phosphorylation of same two membrane-associated proteins  specific to nerve 
tissue. Proc.  Natl. Acad. Sci. USA. 76:2475-2479. 
61.  Smith,  M.  H.  1968. Molecular  weights  of proteins  and  some other 
materials including sedimentation, diffusion, and frictional coefficients and par- 
tial specific volumes, In CRC Handbook of Biochemistry.  3-30. 
62.  Spiegel, J. E., D. S. Beardsley, F. S. Southwick, and S. E. Lux.  1984. 
An analogue of the erythroid  membrane skeleton protein 4.1  in nonerythroid 
cells. J.  Cell Biol.  99:886-893. 
63. Takai, Y., A. Kishimoto, and Y. Nishizuka.  1982. In Calcium and Cell 
Function. W. Y. Cbeung, editor. Academic Press, Inc., New York. 2:386-396. 
64. Trowbridge,  I., and C. Mazauskas.  1976. Immunological properties of 
murine thymus-dependent lymphocyte surface glycoproteins. Eur. J. lmmunol. 
6:557-562. 
65.  Tse,  A.  G.  D.,  N.  Barclay,  A.  Watts,  and  A.  F.  Williams.  1985. A 
glycophospholipid tail at the carboxyl terminus of the Thy-I glycoprotein of 
neurons and thymocytes. Science  (Wash. DC). 230:1003-1008. 
66. Tyler,  J.  M.,  W. R.  Hargraves,  and D. Branton.  1979. Purification of 
two spectrin-binding proteins: biochemical and electron microscopic evidence 
for site specific reassociation between spectrin and band 2.1 and 4.1. Proc. Natl. 
Acad.  Sci. USA. 76:5192-5196. 
67. Tyler,  J.  M., B.  N. Reinhardt,  and D. Branton.  1980. Associations of 
erythrocyte membrane proteins.  Binding of purified bands 2. I and 4.1 to spec- 
trin.  J.  Biol. Chem. 255:7034-7039. 
68.  Ungewickell, E., P. M. Bennett, R. Calvert, V. Ohanian, and N. B. Grat- 
zer.  1979. In vitro formation of a complex between cytoskeletal proteins of the 
human erythrocyte.  Nature  (Lond.).  280:811-814. 
69.  Williams,  A.  F.,  A.  N.  Barclay,  M.  Letarte-Mauirhead,  and  R.  J. 
Morris.  1976. Rat Thy-I antigens from thymus and brain: their tissue distribu- 
tion, purification, and chemical composition. CoM Spring Harbor Symp. Quant. 
Biol.  41:51-61. 
The Journal of Cell Biology, Volume  103, 1986  2540 